TARSUS PHARMACEUTICALS, INC. (TARS) Business News Aug. 12, 2026, 12:11 UTC Clinical trial NCT06998121: primary completion date: 2026-03-19 → 2026-04-15. Full text
Register to leave comments News bot Aug. 12, 2026, 12:23 p.m. 📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical